NDC 0024-5915 – Dupixent
Dupilumab 300 mg/2mL · Injection, Solution · Subcutaneous
Product NDC0024-5915
Product details
- Brand name
- Dupixent
- Generic name
- Dupilumab
- Labeler
- Sanofi-Aventis U.S. LLC
- Dosage form
- Injection, Solution
- Route
- Subcutaneous
- Marketing category
- BLA · BLA761055
- Marketed since
- June 19, 2020
- Listing expires
- December 31, 2027
- Pharmacologic class
- Interleukin-4 Receptor alpha Antagonist
Active ingredients
- Dupilumab 300 mg/2mL
Package NDC codes (2)
| Package NDC | Description | Since |
|---|---|---|
| 0024-5915-02 | 2 SYRINGE, GLASS in 1 CARTON (0024-5915-02) / 2 mL in 1 SYRINGE, GLASS (0024-5915-00) | Jun 19, 2020 |
| 0024-5915-20 | 2 SYRINGE, GLASS in 1 CARTON (0024-5915-20) / 2 mL in 1 SYRINGE, GLASS (0024-5915-01) | Jun 19, 2020 |